Kroger to pay $225K to settle Controlled Substances Act allegations
The US Attorney's Office has announced that Kroger Limited Partnership and Kroger Pharmacy have agreed to pay the United States government $225,000 to settle civil allegations that it violated the Controlled Substances Act (CSA) more than a dozen times at its Rio Hill Center location in Charlottesville, Virginia.
The government says the Kroger store violated the CSA between May 2, 2015 and May 30, 2016. The store was accused of violating the CSA by improperly filling “office use only” prescriptions for Schedule II controlled substances; failing to make and keep DEA 222 order forms; improperly distributing a Schedule II controlled substance without the required DEA 222 form; and failing to provide effective controls and procedures to guard against diversion of controlled substances.
“Pharmacies are vital partners in our collective efforts to reduce the unlawful diversion and use of dangerous opioid drugs,” U.S. Attorney Thomas Cullen says. “As this case illustrates, federal prosecutors will utilize all available tools, including civil actions, to ensure that entities and individuals involved in the lawful dispensing of these potentially deadly drugs fully comply with the law.”
“This case is a great example of how the DEA is doing its part to help end the prescription drug and opioid crisis in our region,” says Jesse Fong, Special Agent in Charge of the Drug Enforcement Administration's Washington field division. “We will continue to work with our law enforcement partners to find and prosecute medical professionals working to illegally distribute these drugs, and will not rest until we see the end of abusive prescribing practices in our area.”